Expert Explains the Greatest Challenge in Treating Patients With MDS and AML

February 11, 2019

Christopher R. Cogle, MD, a professor of medicine at the University of Florida, discusses the greatest challenge in treating patients with myelodysplastic syndromes and acute myeloid leukemia.

Christopher R. Cogle, MD, a professor of medicine at the University of Florida, discusses the greatest challenge in treating patients with myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML).

Both MDS and AML are very heterogenous diseases where a patient has multiple MDS or AML clones, Cogle says. In his research, he found that there were hundreds of genomic abnormalities in each patient.